4tvq - Revision history

OCA at 07:23, 27 September 2023

2023-09-27T07:23:40Z

←Older revision		Revision as of 07:23, 27 September 2023
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4tvq]] is a 5 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TVQ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4TVQ FirstGlance]. <br>		<table><tr><td colspan='2'>[[4tvq]] is a 5 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TVQ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4TVQ FirstGlance]. <br>
-	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4tvq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tvq OCA], [https://pdbe.org/4tvq PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4tvq RCSB], [https://www.ebi.ac.uk/pdbsum/4tvq PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4tvq ProSAT]</span></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.8Å</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4tvq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tvq OCA], [https://pdbe.org/4tvq PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4tvq RCSB], [https://www.ebi.ac.uk/pdbsum/4tvq PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4tvq ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==

OCA at 10:57, 15 March 2023

2023-03-15T10:57:49Z

←Older revision		Revision as of 10:57, 15 March 2023
Line 3:		Line 3:
	<StructureSection load='4tvq' size='340' side='right'caption='[[4tvq]], [[Resolution\|resolution]] 2.80Å' scene=''>		<StructureSection load='4tvq' size='340' side='right'caption='[[4tvq]], [[Resolution\|resolution]] 2.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4tvq]] is a 5 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TVQ OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4TVQ FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4tvq]] is a 5 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TVQ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4TVQ FirstGlance]. <br>
-	</td></tr>~~<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3l8i\|3l8i]], [[3l8j\|3l8j]], [[3rqe\|3rqe]], [[3rqf\|3rqf]], [[3rqg\|3rqg]]</td></tr>~~	+	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4tvq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tvq OCA], [https://pdbe.org/4tvq PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4tvq RCSB], [https://www.ebi.ac.uk/pdbsum/4tvq PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4tvq ProSAT]</span></td></tr>
-	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">PDCD10, CCM3, TFAR15 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>	+
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4tvq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tvq OCA], [~~http~~://pdbe.org/4tvq PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4tvq RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4tvq PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4tvq ProSAT]</span></td></tr>	+
	</table>		</table>
	== Disease ==		== Disease ==
-	[~~[http~~://www.uniprot.org/uniprot/PDC10_HUMAN PDC10_HUMAN]] Hereditary cerebral cavernous malformation. Defects in PDCD10 are the cause of cerebral cavernous malformations type 3 (CCM3) [MIM:[~~http~~://omim.org/entry/603285 603285]]. Cerebral cavernous malformations (CCMs) are congenital vascular anomalies of the central nervous system that can result in hemorrhagic stroke, seizures, recurrent headaches, and focal neurologic deficits. CCMs have an incidence of 0.1%-0.5% in the general population and usually present clinically during the 3rd to 5th decade of life. The lesions are characterized by grossly enlarged blood vessels consisting of a single layer of endothelium and without any intervening neural tissue, ranging in diameter from a few millimeters to several centimeters.<ref>PMID:15543491</ref> ~~[[http://www.uniprot.org/uniprot/CCM2_HUMAN CCM2_HUMAN]] Hereditary cerebral cavernous malformation. The disease is caused by mutations affecting the gene represented in this entry.~~	+	[https://www.uniprot.org/uniprot/PDC10_HUMAN PDC10_HUMAN] Hereditary cerebral cavernous malformation. Defects in PDCD10 are the cause of cerebral cavernous malformations type 3 (CCM3) [MIM:[https://omim.org/entry/603285 603285]. Cerebral cavernous malformations (CCMs) are congenital vascular anomalies of the central nervous system that can result in hemorrhagic stroke, seizures, recurrent headaches, and focal neurologic deficits. CCMs have an incidence of 0.1%-0.5% in the general population and usually present clinically during the 3rd to 5th decade of life. The lesions are characterized by grossly enlarged blood vessels consisting of a single layer of endothelium and without any intervening neural tissue, ranging in diameter from a few millimeters to several centimeters.<ref>PMID:15543491</ref>
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/PDC10_HUMAN PDC10_HUMAN]] Promotes cell proliferation. Modulates apoptotic pathways. Increases mitogen-activated protein kinase activity and MST4 activity. Important for cell migration, and for normal structure and assembly of the Golgi complex. Important for KDR/VEGFR2 signaling. Increases the stability of KDR/VEGFR2 and prevents its breakdown. Required for normal cardiovascular development. Required for normal angiogenesis, vasculogenesis and hematopoiesis during embryonic development (By similarity).<ref>PMID:15543491</ref> <ref>PMID:17360971</ref> <ref>PMID:20332113</ref> [[http://www.uniprot.org/uniprot/CCM2_HUMAN CCM2_HUMAN]] Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity. May act through the stabilization of endothelial cell junctions (By similarity). May function as a scaffold protein for MAP2K3-MAP3K3 signaling. Seems to play a major role in the modulation of MAP3K3-dependent p38 activation induced by hyperosmotic shock (By similarity).	+	[https://www.uniprot.org/uniprot/PDC10_HUMAN PDC10_HUMAN] Promotes cell proliferation. Modulates apoptotic pathways. Increases mitogen-activated protein kinase activity and MST4 activity. Important for cell migration, and for normal structure and assembly of the Golgi complex. Important for KDR/VEGFR2 signaling. Increases the stability of KDR/VEGFR2 and prevents its breakdown. Required for normal cardiovascular development. Required for normal angiogenesis, vasculogenesis and hematopoiesis during embryonic development (By similarity).<ref>PMID:15543491</ref> <ref>PMID:17360971</ref> <ref>PMID:20332113</ref>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 25:		Line 23:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Human~~]]	+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Boggon~~, T J~~]]	+	[[Category: Boggon TJ]]
-	[[Category: Fisher~~, O S~~]]	+	[[Category: Fisher OS]]
-	[[Category: Li, X]]	+	[[Category: Li X]]
-	[[Category: Zhang, R]]	+	[[Category: Zhang R]]
-	~~[[Category: Fat-homology domain]]~~	+
-	~~[[Category: Protein binding~~]]	+

OCA at 08:24, 18 December 2019

2019-12-18T08:24:49Z

←Older revision		Revision as of 08:24, 18 December 2019
Line 1:		Line 1:

	==CCM3 in complex with CCM2 LD-like motif==		==CCM3 in complex with CCM2 LD-like motif==
-	<StructureSection load='4tvq' size='340' side='right' caption='[[4tvq]], [[Resolution\|resolution]] 2.80Å' scene=''>	+	<StructureSection load='4tvq' size='340' side='right'caption='[[4tvq]], [[Resolution\|resolution]] 2.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4tvq]] is a 5 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TVQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4TVQ FirstGlance]. <br>		<table><tr><td colspan='2'>[[4tvq]] is a 5 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TVQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4TVQ FirstGlance]. <br>
Line 26:		Line 26:
	</StructureSection>		</StructureSection>
	[[Category: Human]]		[[Category: Human]]
		+	[[Category: Large Structures]]
	[[Category: Boggon, T J]]		[[Category: Boggon, T J]]
	[[Category: Fisher, O S]]		[[Category: Fisher, O S]]

OCA at 15:01, 15 November 2017

2017-11-15T15:01:25Z

←Older revision		Revision as of 15:01, 15 November 2017
Line 1:		Line 1:
		+
	==CCM3 in complex with CCM2 LD-like motif==		==CCM3 in complex with CCM2 LD-like motif==
	<StructureSection load='4tvq' size='340' side='right' caption='[[4tvq]], [[Resolution\|resolution]] 2.80Å' scene=''>		<StructureSection load='4tvq' size='340' side='right' caption='[[4tvq]], [[Resolution\|resolution]] 2.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4tvq]] is a 5 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TVQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4TVQ FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4tvq]] is a 5 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TVQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4TVQ FirstGlance]. <br>
	</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3l8i\|3l8i]], [[3l8j\|3l8j]], [[3rqe\|3rqe]], [[3rqf\|3rqf]], [[3rqg\|3rqg]]</td></tr>		</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3l8i\|3l8i]], [[3l8j\|3l8j]], [[3rqe\|3rqe]], [[3rqf\|3rqf]], [[3rqg\|3rqg]]</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4tvq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tvq OCA], [http://pdbe.org/4tvq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4tvq RCSB], [http://www.ebi.ac.uk/pdbsum/4tvq PDBsum]</span></td></tr>	+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">PDCD10, CCM3, TFAR15 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4tvq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tvq OCA], [http://pdbe.org/4tvq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4tvq RCSB], [http://www.ebi.ac.uk/pdbsum/4tvq PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4tvq ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
Line 23:		Line 25:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
	[[Category: Boggon, T J]]		[[Category: Boggon, T J]]
	[[Category: Fisher, O S]]		[[Category: Fisher, O S]]

OCA at 23:47, 21 October 2015

2015-10-21T23:47:59Z

←Older revision		Revision as of 23:47, 21 October 2015
Line 4:		Line 4:
	<table><tr><td colspan='2'>[[4tvq]] is a 5 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TVQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4TVQ FirstGlance]. <br>		<table><tr><td colspan='2'>[[4tvq]] is a 5 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TVQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4TVQ FirstGlance]. <br>
	</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3l8i\|3l8i]], [[3l8j\|3l8j]], [[3rqe\|3rqe]], [[3rqf\|3rqf]], [[3rqg\|3rqg]]</td></tr>		</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3l8i\|3l8i]], [[3l8j\|3l8j]], [[3rqe\|3rqe]], [[3rqf\|3rqf]], [[3rqg\|3rqg]]</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4tvq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tvq OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4tvq RCSB], [http://www.ebi.ac.uk/pdbsum/4tvq PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4tvq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tvq OCA], [http://pdbe.org/4tvq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4tvq RCSB], [http://www.ebi.ac.uk/pdbsum/4tvq PDBsum]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
Line 10:		Line 10:
	== Function ==		== Function ==
	[[http://www.uniprot.org/uniprot/PDC10_HUMAN PDC10_HUMAN]] Promotes cell proliferation. Modulates apoptotic pathways. Increases mitogen-activated protein kinase activity and MST4 activity. Important for cell migration, and for normal structure and assembly of the Golgi complex. Important for KDR/VEGFR2 signaling. Increases the stability of KDR/VEGFR2 and prevents its breakdown. Required for normal cardiovascular development. Required for normal angiogenesis, vasculogenesis and hematopoiesis during embryonic development (By similarity).<ref>PMID:15543491</ref> <ref>PMID:17360971</ref> <ref>PMID:20332113</ref> [[http://www.uniprot.org/uniprot/CCM2_HUMAN CCM2_HUMAN]] Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity. May act through the stabilization of endothelial cell junctions (By similarity). May function as a scaffold protein for MAP2K3-MAP3K3 signaling. Seems to play a major role in the modulation of MAP3K3-dependent p38 activation induced by hyperosmotic shock (By similarity).		[[http://www.uniprot.org/uniprot/PDC10_HUMAN PDC10_HUMAN]] Promotes cell proliferation. Modulates apoptotic pathways. Increases mitogen-activated protein kinase activity and MST4 activity. Important for cell migration, and for normal structure and assembly of the Golgi complex. Important for KDR/VEGFR2 signaling. Increases the stability of KDR/VEGFR2 and prevents its breakdown. Required for normal cardiovascular development. Required for normal angiogenesis, vasculogenesis and hematopoiesis during embryonic development (By similarity).<ref>PMID:15543491</ref> <ref>PMID:17360971</ref> <ref>PMID:20332113</ref> [[http://www.uniprot.org/uniprot/CCM2_HUMAN CCM2_HUMAN]] Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity. May act through the stabilization of endothelial cell junctions (By similarity). May function as a scaffold protein for MAP2K3-MAP3K3 signaling. Seems to play a major role in the modulation of MAP3K3-dependent p38 activation induced by hyperosmotic shock (By similarity).
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Mutations in the essential adaptor proteins CCM2 or CCM3 lead to cerebral cavernous malformations (CCM), vascular lesions that most frequently occur in the brain and are strongly associated with hemorrhagic stroke, seizures, and other neurological disorders. CCM2 binds CCM3, but the molecular basis of this interaction, and its functional significance, have not been elucidated. Here, we used x-ray crystallography and structure-guided mutagenesis to show that an alpha-helical LD-like motif within CCM2 binds the highly conserved "HP1" pocket of the CCM3 focal adhesion targeting (FAT) homology domain. By knocking down CCM2 or CCM3 and rescuing with binding-deficient mutants, we establish that CCM2-CCM3 interactions protect CCM2 and CCM3 proteins from proteasomal degradation and show that both CCM2 and CCM3 are required for normal endothelial cell network formation. However, CCM3 expression in the absence of CCM2 is sufficient to support normal cell growth, revealing complex-independent roles for CCM3.
		+
		+	CCM2-CCM3 interaction stabilizes their protein expression and permits endothelial network formation.,Draheim KM, Li X, Zhang R, Fisher OS, Villari G, Boggon TJ, Calderwood DA J Cell Biol. 2015 Mar 30;208(7):987-1001. doi: 10.1083/jcb.201407129. PMID:25825518<ref>PMID:25825518</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 4tvq" style="background-color:#fffaf0;"></div>
	== References ==		== References ==
	<references/>		<references/>

OCA at 14:11, 26 March 2015

2015-03-26T14:11:03Z

←Older revision		Revision as of 14:11, 26 March 2015
Line 1:		Line 1:
-	'''~~Unreleased structure~~'''	+	==CCM3 in complex with CCM2 LD-like motif==
-		+	<StructureSection load='4tvq' size='340' side='right' caption='[[4tvq]], [[Resolution\|resolution]] 2.80Å' scene=''>
-	~~The entry~~ 4tvq is ~~ON HOLD until Paper Publication~~	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[4tvq]] is a 5 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TVQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4TVQ FirstGlance]. <br>
-	~~Authors~~: Li, X., ~~Zhang~~, R., ~~Fisher~~, O.S., ~~Boggon, T~~.J.	+	</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3l8i\|3l8i]], [[3l8j\|3l8j]], [[3rqe\|3rqe]], [[3rqf\|3rqf]], [[3rqg\|3rqg]]</td></tr>
-		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4tvq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tvq OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4tvq RCSB], [http://www.ebi.ac.uk/pdbsum/4tvq PDBsum]</span></td></tr>
-	~~Description:~~	+	</table>
-	[[~~Category~~: ~~Unreleased Structures~~]]	+	== Disease ==
-	[[~~Category~~: ~~Fisher~~, O.S]]	+	[[http://www.uniprot.org/uniprot/PDC10_HUMAN PDC10_HUMAN]] Hereditary cerebral cavernous malformation. Defects in PDCD10 are the cause of cerebral cavernous malformations type 3 (CCM3) [MIM:[http://omim.org/entry/603285 603285]]. Cerebral cavernous malformations (CCMs) are congenital vascular anomalies of the central nervous system that can result in hemorrhagic stroke, seizures, recurrent headaches, and focal neurologic deficits. CCMs have an incidence of 0.1%-0.5% in the general population and usually present clinically during the 3rd to 5th decade of life. The lesions are characterized by grossly enlarged blood vessels consisting of a single layer of endothelium and without any intervening neural tissue, ranging in diameter from a few millimeters to several centimeters.<ref>PMID:15543491</ref> [[http://www.uniprot.org/uniprot/CCM2_HUMAN CCM2_HUMAN]] Hereditary cerebral cavernous malformation. The disease is caused by mutations affecting the gene represented in this entry.
-	[[Category: Boggon, T.J]]	+	== Function ==
		+	[[http://www.uniprot.org/uniprot/PDC10_HUMAN PDC10_HUMAN]] Promotes cell proliferation. Modulates apoptotic pathways. Increases mitogen-activated protein kinase activity and MST4 activity. Important for cell migration, and for normal structure and assembly of the Golgi complex. Important for KDR/VEGFR2 signaling. Increases the stability of KDR/VEGFR2 and prevents its breakdown. Required for normal cardiovascular development. Required for normal angiogenesis, vasculogenesis and hematopoiesis during embryonic development (By similarity).<ref>PMID:15543491</ref> <ref>PMID:17360971</ref> <ref>PMID:20332113</ref> [[http://www.uniprot.org/uniprot/CCM2_HUMAN CCM2_HUMAN]] Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity. May act through the stabilization of endothelial cell junctions (By similarity). May function as a scaffold protein for MAP2K3-MAP3K3 signaling. Seems to play a major role in the modulation of MAP3K3-dependent p38 activation induced by hyperosmotic shock (By similarity).
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Boggon, T J]]
		+	[[Category: Fisher, O S]]
	[[Category: Li, X]]		[[Category: Li, X]]
	[[Category: Zhang, R]]		[[Category: Zhang, R]]
		+	[[Category: Fat-homology domain]]
		+	[[Category: Protein binding]]

OCA at 17:54, 24 December 2014

2014-12-24T17:54:16Z

←Older revision		Revision as of 17:54, 24 December 2014
Line 5:		Line 5:
	Authors: Li, X., Zhang, R., Fisher, O.S., Boggon, T.J.		Authors: Li, X., Zhang, R., Fisher, O.S., Boggon, T.J.

-	Description:	+	Description:
		+	[[Category: Unreleased Structures]]
		+	[[Category: Fisher, O.S]]
		+	[[Category: Boggon, T.J]]
		+	[[Category: Li, X]]
		+	[[Category: Zhang, R]]

OCA at 09:56, 16 July 2014

2014-07-16T09:56:14Z

←Older revision		Revision as of 09:56, 16 July 2014
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 4tvq is ON HOLD	+	The entry 4tvq is ON HOLD until Paper Publication

	Authors: Li, X., Zhang, R., Fisher, O.S., Boggon, T.J.		Authors: Li, X., Zhang, R., Fisher, O.S., Boggon, T.J.

	Description:		Description:

OCA: Protected "4tvq" [edit=sysop:move=sysop]

2014-07-09T06:59:08Z

Protected "4tvq" [edit=sysop:move=sysop]

←Older revision

Revision as of 06:59, 9 July 2014

OCA: New page: '''Unreleased structure''' The entry 4tvq is ON HOLD Authors: Li, X., Zhang, R., Fisher, O.S., Boggon, T.J. Description:

2014-07-09T06:59:07Z

New page: '''Unreleased structure''' The entry 4tvq is ON HOLD Authors: Li, X., Zhang, R., Fisher, O.S., Boggon, T.J. Description:

New page

'''Unreleased structure'''

The entry 4tvq is ON HOLD

Authors: Li, X., Zhang, R., Fisher, O.S., Boggon, T.J.

Description: